Hana Pharm Co., Ltd. (293480.KS)

KRW 10850.0

(-0.73%)

Operating Expenses Summary of Hana Pharm Co., Ltd.

  • Hana Pharm Co., Ltd.'s latest annual operating expenses in 2023 was 114.72 Billion KRW , up 14.65% from previous year.
  • Hana Pharm Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 151.57 Billion KRW , up 442.74% from previous quarter.
  • Hana Pharm Co., Ltd. reported a annual operating expenses of 100.06 Billion KRW in annual operating expenses 2022, up 5.55% from previous year.
  • Hana Pharm Co., Ltd. reported a annual operating expenses of 94.8 Billion KRW in annual operating expenses 2021, up 15.13% from previous year.
  • Hana Pharm Co., Ltd. reported a quarterly operating expenses of 151.57 Billion KRW for 2024 Q2, up 442.74% from previous quarter.
  • Hana Pharm Co., Ltd. reported a quarterly operating expenses of -28.78 Billion KRW for 2023 Q3, down -4.32% from previous quarter.

Annual Operating Expenses Chart of Hana Pharm Co., Ltd. (2023 - 2015)

Historical Annual Operating Expenses of Hana Pharm Co., Ltd. (2023 - 2015)

Year Operating Expenses Operating Expenses Growth
2023 114.72 Billion KRW 14.65%
2022 100.06 Billion KRW 5.55%
2021 94.8 Billion KRW 15.13%
2020 82.34 Billion KRW 7.46%
2019 76.63 Billion KRW 12.13%
2018 68.34 Billion KRW 9.44%
2017 62.44 Billion KRW 3.66%
2016 60.24 Billion KRW 9.62%
2015 54.95 Billion KRW 0.0%

Peer Operating Expenses Comparison of Hana Pharm Co., Ltd.

Name Operating Expenses Operating Expenses Difference
Yuyu Pharma, Inc. 47.25 Billion KRW -142.784%
Dong-A Socio Holdings Co., Ltd. 297.99 Billion KRW 61.501%
Ildong Holdings Co., Ltd. 278.43 Billion KRW 58.797%
HANDOK Inc. 153.76 Billion KRW 25.391%
Kukje Pharma Co., Ltd. 69.21 Billion KRW -65.755%
Yuhan Corporation 489.94 Billion KRW 76.584%
Dong-A ST Co., Ltd. 306.95 Billion KRW 62.625%
SAMSUNG PHARM. Co., LTD. 41.78 Billion KRW -174.531%
Hanmi Pharm. Co., Ltd. 610.97 Billion KRW 81.222%
Hanall Biopharma Co.,Ltd 71.98 Billion KRW -59.377%
Ilyang Pharmaceutical Co.,Ltd 174.14 Billion KRW 34.122%
Dong Sung Bio Pharm.Co.,Ltd. 40.05 Billion KRW -186.432%
MYUNGMOON Pharm co.,Ltd 93.55 Billion KRW -22.633%
Yuyu Pharma, Inc. 47.25 Billion KRW -142.784%
Ilsung Pharmaceuticals Co., Ltd. 42.47 Billion KRW -170.121%
REYON Pharmaceutical Co., Ltd. 75.04 Billion KRW -52.866%
Aprogen pharmaceuticals,Inc. 58.64 Billion KRW -95.629%
JW Holdings Corporation 301.25 Billion KRW 61.918%
Ildong Pharmaceutical Co., Ltd. 260.95 Billion KRW 56.037%
Chong Kun Dang Pharmaceutical Corp. 408.65 Billion KRW 71.926%
JW Pharmaceutical Corporation 238.91 Billion KRW 51.98%
Shin Poong Pharm.Co.,Ltd. 127.66 Billion KRW 10.139%
Hyundai Pharmaceutical Co., Ltd. 68.31 Billion KRW -67.945%
Samil Pharmaceutical Co.,Ltd 65.75 Billion KRW -74.483%
Jeil Pharmaceutical Co.,Ltd 174.92 Billion KRW 34.415%
Yuyu Pharma, Inc. 47.25 Billion KRW -142.784%
Kwang Dong Pharmaceutical Co., Ltd. 249.12 Billion KRW 53.948%
Daewoong pharmaceutical Co.,Ltd 560.43 Billion KRW 79.529%
JW Pharmaceutical Corporation 238.91 Billion KRW 51.98%
Yuhan Corporation 489.94 Billion KRW 76.584%
Jeil Pharma Holdings Inc 193.66 Billion KRW 40.761%
Yungjin Pharm. Co., Ltd. 69.46 Billion KRW -65.147%
Suheung Co., Ltd. 56.03 Billion KRW -104.749%
JW Pharmaceutical Corporation 238.91 Billion KRW 51.98%
Samjin Pharmaceuticals Co., Ltd. 126.39 Billion KRW 9.231%
Korea United Pharm Inc. 118.21 Billion KRW 2.951%
CKD Bio Corp. 25.19 Billion KRW -355.335%
Daewon Pharmaceutical Co., Ltd. 221.99 Billion KRW 48.322%
Dongwha Pharm.Co.,Ltd 165.11 Billion KRW 30.517%
Whan In Pharm Co.,Ltd. 66.41 Billion KRW -72.733%
Shin Poong Pharm.Co.,Ltd. 127.66 Billion KRW 10.139%
Chong Kun Dang Holdings Corp. 350.71 Billion KRW 67.288%
Boryung Corporation 285.16 Billion KRW 59.768%
Bukwang Pharmaceutical Co., Ltd. 87.54 Billion KRW -31.051%
Ilyang Pharmaceutical Co.,Ltd 174.14 Billion KRW 34.122%
JW Lifescience Corporation 20.26 Billion KRW -466.219%